Abstract
One of the major obstacles to effective prolonged CD8 T cell control over HIV and other latent infections may be the intrinsic, genetically programmed barrier to unlimited proliferation that is characteristic of all normal human somatic cells. Replicative senescence, characterized extensively in cell culture for a variety of cell types, comprises both irreversible cell cycle arrest and striking changes in function. CD8 T cells with features similar to senescent CD8 T cell cultures (i.e., absence of CD28, inability to proliferate, telomeres in the 5-7 kb range, resistance to apoptosis) increase progressively during aging and in chronic HIV infection, suggesting that replicative senescence may be occurring in vivo, and, in fact, may constitute the final stage in the normal differentiation of human T cells. CD8 T cells with characteristics suggestive of senescence have also been implicated in modulating immune function and altering bone homeostasis. Further characterization of the underlying mechanism leading to the generation of senescent memory CD8 T cells and analysis of their functional attributes will help elucidate their role in HIV disease pathogenesis.
Keywords: Replicative senescence,, CD8 T cells,, HIV,, aging.
Current HIV Research
Title: Replicative Senescence: The Final Stage of Memory T Cell Differentiation?
Volume: 1 Issue: 2
Author(s): Rita B. Effros
Affiliation:
Keywords: Replicative senescence,, CD8 T cells,, HIV,, aging.
Abstract: One of the major obstacles to effective prolonged CD8 T cell control over HIV and other latent infections may be the intrinsic, genetically programmed barrier to unlimited proliferation that is characteristic of all normal human somatic cells. Replicative senescence, characterized extensively in cell culture for a variety of cell types, comprises both irreversible cell cycle arrest and striking changes in function. CD8 T cells with features similar to senescent CD8 T cell cultures (i.e., absence of CD28, inability to proliferate, telomeres in the 5-7 kb range, resistance to apoptosis) increase progressively during aging and in chronic HIV infection, suggesting that replicative senescence may be occurring in vivo, and, in fact, may constitute the final stage in the normal differentiation of human T cells. CD8 T cells with characteristics suggestive of senescence have also been implicated in modulating immune function and altering bone homeostasis. Further characterization of the underlying mechanism leading to the generation of senescent memory CD8 T cells and analysis of their functional attributes will help elucidate their role in HIV disease pathogenesis.
Export Options
About this article
Cite this article as:
Effros B. Rita, Replicative Senescence: The Final Stage of Memory T Cell Differentiation?, Current HIV Research 2003; 1 (2) . https://dx.doi.org/10.2174/1570162033485348
DOI https://dx.doi.org/10.2174/1570162033485348 |
Print ISSN 1570-162X |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4251 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Dental Pulp from Human Exfoliated Deciduous Teeth-derived Stromal Cells Demonstrated Neuronal Potential: In Vivo and In Vitro Studies
Current Stem Cell Research & Therapy Dietary Polyphenols for Treatment of Alzheimer’s Disease– Future Research and Development
Current Pharmaceutical Biotechnology Clinical Experience with Antiangiogenic Therapy in Leukemia
Current Cancer Drug Targets Histone Variants and Composition in the Developing Brain: Should MeCP2 Care?
Current Topics in Medicinal Chemistry Molecular Mechanisms and Biological Significance of CTL Avidity
Current HIV Research Fused Xanthone Derivatives as Antiproliferative Agents
Anti-Cancer Agents in Medicinal Chemistry Gonioprobe, an Innovative Gamma-probe to Guide Parathyroid Radioguided Surgery: First Clinical Experiences with Navigator and Lock-ontarget Functions
Current Radiopharmaceuticals Evaluating 3D-printed Bolus Compared to Conventional Bolus Types Used in External Beam Radiation Therapy
Current Medical Imaging Targeting RGD Recognizing Integrins: Drug Development, Biomaterial Research, Tumor Imaging and Targeting
Current Pharmaceutical Design RING Finger E3 Ubiquitin Ligases: Structure and Drug Discovery
Current Pharmaceutical Design Preparation and Antitumor Effect of N-Trimethylchitosan/Fucoidan Ion-Complex Submicron Particles
Current Nanoscience Feud or Friend? The Role of the miR-17-92 Cluster in Tumorigenesis
Current Genomics Synthesis and Anti-Proliferative Activity of New Biphenyle-Benzylidenethiazolidine- 2,4-dione Bis-Adducts Containing Various Heterocyclic Cores
Letters in Drug Design & Discovery Nuclear Factor Kappa B: A Potential Target for Anti-HIV Chemotherapy
Current Medicinal Chemistry Genetic Modification of Natural Killer Cells for Leukemia Therapies
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Combined Chemotherapy or Biotherapy with Jasmonates: Targeting Energy Metabolism for Cancer Treatment
Current Pharmaceutical Biotechnology Bergamot Juice Extract Inhibits Proliferation by Inducing Apoptosis in Human Colon Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Predicting Chemotherapy Sensitivity Profiles for Breast Cancer Cell Lines with and Without Stem Cell-Like Features
Current Signal Transduction Therapy Ignored Avenues in Alpha-Synuclein Associated Proteopathy
CNS & Neurological Disorders - Drug Targets Targeting Oncogenes and Tumor Suppressors genes to Mitigate Chemoresistance
Current Cancer Drug Targets